Search results
New weight loss drugs are coming, and they could burn more fat with fewer side effects
NBC News via Yahoo News· 7 hours agoIncreased competition could drive down the high cost of the drugs over time. A month’s supply of ...
'Novo Nordisk is ripping off the American people,' Bernie Sanders says of Ozempic and Wegovy costs
NBC News via Yahoo News· 3 days agoSen. Bernie Sanders says the first question he is going to ask Novo Nordisk's CEO at a committee...
Ozempic, Wegovy Maker Agrees to Tesitfy on Senate Hearing for Overpricing Concerns
iTech Post· 6 days agoOzempic and Wegovy maker Novo Nordisk will finally testify to the Senate amid growing concerns about...
Why Bernie Sanders’ Ozempic crusade is misguided
Dallas Morning News· 6 days agoIt’s not surprising that Sanders, one of the most vociferous critics of the pharmaceutical industry in Congress, would take such a critical approach.
Saxenda injections for weight loss: Side effects and benefits
Daily Telegraph· 7 days agoInterest in the weight loss drug Saxenda has skyrocketed. Saxenda is a form of prescription weight...
Baggy pants are out and smaller sizes are flying off the shelves as Wegovy changes how Americans buy...
Fortune via AOL· 6 days agoSales at clothing and clothing accessory stores have remained flat at just under $26 billion per...
Drugmaker to testify on why weight-loss drugs cost 15x more in the US
Ars Technica· 6 days agoAfter some persuasion from Sen. Bernie Sanders (I-Vt.), the CEO of Novo Nordisk will testify before...
Ozempic is 1,300% more expensive in the U.S. vs the U.K.—so the boss of Novo Nordisk is being hauled...
Fortune via Yahoo Finance· 7 days agoSenate to defend the massive markup Americans pay compared to Brits and Europeans. Ozempic’s U.S....
Bernie Sanders will grill Novo Nordisk's CEO over Ozempic and Wegovy prices
Quartz· 7 days agoCEO Lars Fruergaard Jørgensen will testify before the Senate's health committee after Sanders...
Gateway - Quartz
Quartz· 6 days agoPharma giant AstraZeneca aims to increase its revenue by a whopping 75% in 2030, up from the $45.8 billion it generated...as it pulls its COVID-19 vaccines off the shelves. Meanwhile, Pfizer ...
